AMBRISENTAN - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

volibris

glaxosmithkline nz limited - ambrisentan 10mg - tablet - 10 mg - active: ambrisentan 10mg excipient: croscarmellose sodium opadry ii red 85g94101 lactose magnesium stearate microcrystalline cellulose - volibris is indicated for the treatment of: · idiopathic pulmonary arterial hypertension (pah) · pulmonary arterial hypertension associated with connective tissue disease (pah-ctd) in patients with who functional class ii, iii or iv symptoms.

New Zealand - English - Medsafe (Medicines Safety Authority)

volibris

glaxosmithkline nz limited - ambrisentan 5mg - tablet - 5 mg - active: ambrisentan 5mg excipient: croscarmellose sodium opadry ii pink 85g94065 lactose magnesium stearate microcrystalline cellulose - volibris is indicated for the treatment of: · idiopathic pulmonary arterial hypertension (pah) · pulmonary arterial hypertension associated with connective tissue disease (pah-ctd) in patients with who functional class ii, iii or iv symptoms.

European Union - English - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - hypertension, pulmonary - antihypertensives, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.1). efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.1).

Australia - English - Department of Health (Therapeutic Goods Administration)

ambricip ambrisentan 5 mg tablet blister pack

cipla australia pty ltd - ambrisentan, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; allura red ac aluminium lake; polyvinyl alcohol; macrogol 3350; lecithin - ambricip is indicated for the treatment of: - idiopathic pulmonary arterial hypertension (pah), - pulmonary artrial hypertension associated with connective tissue disease (pah-ctd),,in patients with who functional class ii, iii or iv symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

ambricip ambrisentan 10 mg tablet blister pack

cipla australia pty ltd - ambrisentan, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; allura red ac aluminium lake; polyvinyl alcohol; macrogol 3350; lecithin - ambricip is indicated for the treatment of: - idiopathic pulmonary arterial hypertension (pah), - pulmonary artrial hypertension associated with connective tissue disease (pah-ctd),,in patients with who functional class ii, iii or iv symptoms.